Sino Biological Inc banner

Sino Biological Inc
SZSE:301047

Watchlist Manager
Sino Biological Inc Logo
Sino Biological Inc
SZSE:301047
Watchlist
Price: 72.67 CNY -2.64% Market Closed
Market Cap: ¥8.8B

Sino Biological Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sino Biological Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biological Inc
SZSE:301047
EPS (Diluted)
¥1
CAGR 3-Years
-20%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
RemeGen Co Ltd
SSE:688331
EPS (Diluted)
¥1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
EPS (Diluted)
-¥1
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
EPS (Diluted)
-¥1
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sino Biological Inc
Glance View

Market Cap
8.8B CNY
Industry
Biotechnology

Sino Biological Inc. emerged as a pivotal player in the life sciences sphere from its inception, carving a niche through its extensive portfolio of biological reagents, particularly recombinant proteins and antibodies. This Beijing-headquartered company swiftly gained acclaim by developing high-quality, cost-effective products that cater to the needs of researchers, pharmaceutical companies, and biotechnology firms worldwide. Its expansive catalog, boasting thousands of products, is meticulously curated to support research and development in areas such as immunology, cancer research, and infectious diseases. Sino Biological’s facility, equipped with state-of-the-art technology, combines automation with expert human oversight to ensure precision in production, fundamentally driving its reputation for reliability and innovation. At the heart of Sino Biological’s business model lies a commitment to accelerating the pace of biomedical research through its comprehensive suite of products and services. The company generates revenue by not only selling its own products but also by offering custom services, including protein production, antibody development, and assay development, tailored to meet specific client needs. By employing a business strategy that emphasizes collaboration and tailored solutions, Sino Biological successfully fosters long-term partnerships with its clients. This approach not only fortifies its foothold in the industry but also ensures a steady income stream as it plays a vital role in facilitating breakthroughs in medical research and development globally.

Intrinsic Value
53.37 CNY
Overvaluation 27%
Intrinsic Value
Price ¥72.67

See Also

What is Sino Biological Inc's EPS (Diluted)?
EPS (Diluted)
1.2 CNY

Based on the financial report for Dec 31, 2025, Sino Biological Inc's EPS (Diluted) amounts to 1.2 CNY.

What is Sino Biological Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-33%

Over the last year, the EPS (Diluted) growth was 27%. The average annual EPS (Diluted) growth rates for Sino Biological Inc have been -20% over the past three years , -33% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett